Clinical Trial Results:
Nemorubicin hydrochloride (PNU-152243A) administered via intrahepatic artery in combination with cisplatin in adult patients with unresectable hepatocellular carcinoma: Phase II study preceded by dose-escalation.
Summary
|
|
EudraCT number |
2005-000731-26 |
Trial protocol |
GB IT DE FR |
Global completion date |
19 Apr 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 May 2016
|
First version publication date |
08 May 2016
|
Other versions |
|
Summary report(s) |
NEMORUBICIN IN COMBINATION WITH CISPLATIN IN ADULT PATIENTS WITH HEPATOCELLULAR CARCINOMA |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.